Dopamine

5-hydroxytryptamine receptor 2C ; Homo sapiens







16 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 27903793 The serotonin 5-HT2C receptor and the non-addictive nature of classic hallucinogens. 2017 Jan 1
2 24661380 Serotonin2C receptors modulate dopamine transmission in the nucleus accumbens independently of dopamine release: behavioral, neurochemical and molecular studies with cocaine. 2015 May 2
3 25542858 Serotonin-2C antagonism augments the effect of citalopram on serotonin and dopamine levels in the ventral tegmental area and nucleus accumbens. 2015 Feb 2
4 25569089 Agomelatine beyond borders: current evidences of its efficacy in disorders other than major depression. 2015 Jan 5 1
5 24504487 Reduction of parkinsonism and psychosis with mirtazapine: a case report. 2014 May 1
6 22328576 Effects of serotonin 2C receptor agonists on the behavioral and neurochemical effects of cocaine in squirrel monkeys. 2012 May 2
7 22764241 Striatal dopamine release and genetic variation of the serotonin 2C receptor in humans. 2012 Jul 4 1
8 20953589 Presynaptic control of serotonin on striatal dopamine function. 2011 Feb 1
9 19690620 Polymorphisms of serotonin receptor 2A and 2C genes and COMT in relation to obesity and type 2 diabetes. 2009 Aug 19 1
10 20135898 Pharmacogenetics of antipsychotic-induced side effects. 2009 1
11 16475958 Modulation of dopamine transmission by 5HT2C and 5HT3 receptors: a role in the antidepressant response. 2006 Feb 2
12 15668911 Modulation of dopamine release by striatal 5-HT2C receptors. 2005 Mar 15 4
13 15717293 Serotonin receptor 2C (HTR2C) and schizophrenia: examination of possible medication and genetic influences on expression levels. 2005 Apr 5 1
14 12974395 Serotonin/dopamine interaction--focus on 5-HT2C receptor, a new target of psychotropic drugs. 2002 Dec 4
15 10206238 Allelic variants of dopamine receptor D4 (DRD4) and serotonin receptor 5HT2c (HTR2c) and temperament factors: replication tests. 1999 Apr 16 1
16 10494451 HTR2C Cys23Ser polymorphism in relation to CSF monoamine metabolite concentrations and DSM-III-R psychiatric diagnoses. 1999 Sep 15 1